Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human MAPK9 Anticorps:
anti-Mouse (Murine) MAPK9 Anticorps:
anti-Rat (Rattus) MAPK9 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal MAPK9 Primary Antibody pour IHC (p), WB - ABIN1882172
Gupta, Barrett, Whitmarsh, Cavanagh, Sluss, Dérijard, Davis: Selective interaction of JNK protein kinase isoforms with transcription factors. dans The EMBO journal 1996
Show all 4 Pubmed References
Human Polyclonal MAPK9 Primary Antibody pour ELISA, WB - ABIN4327970
Leppä, Bohmann: Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. dans Oncogene 1999
The MAP kinase (Montrer MAPK1 Anticorps) JNK2 mediates cigarette smoke-induced tissue factor (Montrer F3 Anticorps) activation, arterial thrombosis and reactive oxygen species production.
We found p-JNK2 up-regulation in AUC and its early down-regulation in UC-CRC (Montrer CALR Anticorps) and CRC (Montrer CALR Anticorps) carcinogenesis.
JNK2 was a novel direct target of miR (Montrer MLXIP Anticorps)-20a-5p.
The release of infectious respiratory syncytial virus (RSV) virions from infected cells was significantly reduced by JNK1 (Montrer MAPK8 Anticorps)/2 siRNA knockdown, implicating JNK1 (Montrer MAPK8 Anticorps)/2 as a key host factor for RSV virus production.
PXR (Montrer NR1I2 Anticorps) regulates the intestinal epithelial barrier during inflammation by modulating cytokine-induced MLCK (Montrer MYLK Anticorps) expression and JNK1 (Montrer MAPK8 Anticorps)/2 activation
Phloretin is able to inhibit NSCLC A549 cell growth by inducing apoptosis through P38 MAPK (Montrer MAPK14 Anticorps) and JNK1 (Montrer MAPK8 Anticorps)/2 pathways, and therefore may prove to be an adjuvant to the treatment of non-small cell lung cancer
In hepatocytes, JNK1 (Montrer MAPK8 Anticorps) and JNK2 appear to have combined effects in protecting from drug-induced liver injury.
Inhibition of JNK1 (Montrer MAPK8 Anticorps)/2 activity suppressed Hedgehog (Montrer SHH Anticorps) pathway activity in acquired chemoresistant cancer cells.
although JNK (Montrer MAPK8 Anticorps) activation and RIP3 (Montrer RIPK3 Anticorps) expression are induced by FS, neither contributes to the liver injury.
These data suggest that JNK1 (Montrer MAPK8 Anticorps)/2 may play an important role in promoting the replication of Penicillium marneffei.
activation of JNK (Montrer MAPK8 Anticorps) in the endoplasmic reticulum stress response precedes activation of XBP1 (Montrer XBP1 Anticorps).
JNK-2 regulates aggrecan (Montrer ACAN Anticorps) degradation in cultured murine cartilage and surgically induced osteoarthritis in vivo following mechanical destabilization of the knee joint.
activation of astrocyte MMP2 (Montrer MMP2 Anticorps)/JNK1 (Montrer MAPK8 Anticorps)/2 contributes to the pathogenesis of pain hypersensitivity in the complex regional pain syndrome model
JNK1 (Montrer MAPK8 Anticorps)/2-dependent regulation of p66ShcS36 phosphorylation, is reported.
This study demonstrated that the disruption of JNK2 appears to have a greater impact on tolerance than the other isoforms in the tail-flick but not the hot-plate test.
although JNK (Montrer MAPK8 Anticorps) activation and RIP3 (Montrer MPRIP Anticorps) expression are induced by FS, neither contributes to the liver injury.
morphine activated JNK2 through an arrestin-independent Src- and PKC-dependent mechanism, whereas fentanyl activated JNK2 through a Src-GRK3/arrestin-2-dependent and PKC-independent mechanism.
studies herein support that JNK2 inhibits cell differentiation in normal and cancer-derived mammary cells
this study indicates that JNK2 is a physiological kinase responsible for eNOS (Montrer NOS3 Anticorps)-Ser (Montrer SIGLEC1 Anticorps)(116) phosphorylation and regulates NO production.
Data show that proinflammatory cytokines induction was ERK1/2 and JNK1 (Montrer MAPK8 Anticorps)/2 dependent.
These data suggest that the p38 (Montrer MAPK14 Anticorps) and JNK (Montrer MAPK8 Anticorps) signaling pathways play pivotal roles in PRRSV replication and may regulate immune responses during virus infection.
MPK9 and MPK12 (Montrer MAPK12 Anticorps) are positive regulators of salicylic acid signaling in Arabidopsis guard cells.
MPK9 and MPK12 (Montrer MAPK12 Anticorps) are key regulators mediating both abscisic acid (ABA) and Methyl jasmonate (MeJA) signalling in guard cells.
Data suggest that MPK9 is autoactivated via phosphorylation independent of any upstream MAPK (Montrer MAPK1 Anticorps) kinase signaling; autophosphorylation occurs at both threonine and tyrosine residues in Thr (Montrer TRH Anticorps)-Asp (Montrer ASIP Anticorps)-Tyr (Montrer TYR Anticorps) motif and in C-terminal regulatory extension.
MPK9 and MPK12 (Montrer MAPK12 Anticorps) function redundantly downstream of extracellular reactive oxygen production and intracellular accumulation, cytosolic alkalisation and Ca(2 (Montrer CA2 Anticorps)+)cytosolic oscillation in yeast elcictor-induced stomatal closure
MPK9 and MPK12 (Montrer MAPK12 Anticorps) act downstream of ROS (Montrer ROS1 Anticorps) and cytosolic Ca2 (Montrer CA2 Anticorps)+ and upstream of anion channels in the guard cell abscisic acid signaling cascade.
MAP kinases MPK9 and MPK12 (Montrer MAPK12 Anticorps) are preferentially expressed in guard cells and positively regulate ROS (Montrer ROS1 Anticorps)-mediated ABA signaling.
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene's mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported.
mitogen-activated protein kinase 9
, Jun kinase
, MAP kinase 9
, MAPK 9
, c-Jun N-terminal kinase 2
, c-Jun kinase 2
, stress-activated protein kinase 1a
, stress-activated protein kinase JNK2
, JNK/SAPK alpha
, mitogen activated protein kinase 9
, protein kinase, mitogen-activated 9
, stress activated protein kinase alpha II
, janus kinase 2
, c-JUN amino-terminal kinase-2 alpha1